The SARS-CoV-2 NGS Assay is a highly sensitive nucleic acid hybridization capture-based assay used for the detection of the SARS-CoV-2 virus under emergency use authorization from the FDA. It utilizes Twist Bioscience’s unique ability to rapidly develop virus-specific panels through precision DNA synthesis, and Biotia’s comprehensive data analysis software and reporting capabilities (COVID-DX (v1.0)). Because the assay analyzes the full sequence data, the test reduces the likelihood of a false-negative result. In contrast, a majority of SARS-CoV-2 tests based on polymerase chain reaction (PCR) only identify limited genetic markers of the virus.

For SARS-CoV-2 NGS Assay - RUO, please visit the product page here.